Mallincrodt acquiring Ocera

Mallinckrodt plc (NYSE:MNK) will acquire Ocera Therapeutics Inc. (NASDAQ:OCRX) for $1.52 per share in a deal the companies say values Ocera at about $42 million. Ocera's shareholders are also eligible to receive a Contingent Value Right worth up to $2.58 per share, or about $75 million, upon achievement of milestones. The price is a 52% premium to Ocera’s close of $1 on Nov. 1, the day before the deal was announced. The deal is due to close this year...